Tina Moore
👤 PersonAppearances Over Time
Podcast Appearances
You are tuned into the Dr. Tina Show with Dr. Tina Moore. For more, visit drtina.com. On this episode of The Dr. Tina Show, I'm so excited to bring on Dr. Spencer Nadolski. Dr. Nadolski is someone I've been following for a long time on Instagram. He's an obesity specialist. He's a lipidologist. He also is the owner and founder of Vineyard, which is an online direct care model.
You are tuned into the Dr. Tina Show with Dr. Tina Moore. For more, visit drtina.com. On this episode of The Dr. Tina Show, I'm so excited to bring on Dr. Spencer Nadolski. Dr. Nadolski is someone I've been following for a long time on Instagram. He's an obesity specialist. He's a lipidologist. He also is the owner and founder of Vineyard, which is an online direct care model.
You are tuned into the Dr. Tina Show with Dr. Tina Moore. For more, visit drtina.com. On this episode of The Dr. Tina Show, I'm so excited to bring on Dr. Spencer Nadolski. Dr. Nadolski is someone I've been following for a long time on Instagram. He's an obesity specialist. He's a lipidologist. He also is the owner and founder of Vineyard, which is an online direct care model.
He specializes in GLP-1s and we are going to have the obesity conversation that you all have been asking me for. You know I've been talking about these peptides for a long time outside of weight loss, outside of type 2 diabetes, although my message has been skewed over the past few years.
He specializes in GLP-1s and we are going to have the obesity conversation that you all have been asking me for. You know I've been talking about these peptides for a long time outside of weight loss, outside of type 2 diabetes, although my message has been skewed over the past few years.
He specializes in GLP-1s and we are going to have the obesity conversation that you all have been asking me for. You know I've been talking about these peptides for a long time outside of weight loss, outside of type 2 diabetes, although my message has been skewed over the past few years.
I've been trying to talk about them in relation to all of the other benefits throughout the body that they may or may not have in the clinical data. That said, this is an important conversation to have. We need to talk about obesity as a disease, and I need folks to really understand what that means. And I can't think of a better person for the job than Dr. Nadolski.
I've been trying to talk about them in relation to all of the other benefits throughout the body that they may or may not have in the clinical data. That said, this is an important conversation to have. We need to talk about obesity as a disease, and I need folks to really understand what that means. And I can't think of a better person for the job than Dr. Nadolski.
I've been trying to talk about them in relation to all of the other benefits throughout the body that they may or may not have in the clinical data. That said, this is an important conversation to have. We need to talk about obesity as a disease, and I need folks to really understand what that means. And I can't think of a better person for the job than Dr. Nadolski.
So without further ado, let's jump in. Dr. Spencer Nadolski, I'm so excited to have you on the Dr. Tina show today. And we are going to talk all things obesity, GLP-1s. This is a conversation I wanted to have because I've been trying to
So without further ado, let's jump in. Dr. Spencer Nadolski, I'm so excited to have you on the Dr. Tina show today. And we are going to talk all things obesity, GLP-1s. This is a conversation I wanted to have because I've been trying to
So without further ado, let's jump in. Dr. Spencer Nadolski, I'm so excited to have you on the Dr. Tina show today. And we are going to talk all things obesity, GLP-1s. This is a conversation I wanted to have because I've been trying to
seeing the praises of glp-1 agonists outside of obesity and weight loss and type 2 diabetes just more in a metabolic health cardiovascular uh you know neuroprotective way and everybody's been begging me to bring on an obesity doctor and a specialist like yourself so here we are thank you for coming we're doing it yes i'm excited i'm excited so i've been following you for years and i'm a huge fan of your work and i see more often than not these days
seeing the praises of glp-1 agonists outside of obesity and weight loss and type 2 diabetes just more in a metabolic health cardiovascular uh you know neuroprotective way and everybody's been begging me to bring on an obesity doctor and a specialist like yourself so here we are thank you for coming we're doing it yes i'm excited i'm excited so i've been following you for years and i'm a huge fan of your work and i see more often than not these days
seeing the praises of glp-1 agonists outside of obesity and weight loss and type 2 diabetes just more in a metabolic health cardiovascular uh you know neuroprotective way and everybody's been begging me to bring on an obesity doctor and a specialist like yourself so here we are thank you for coming we're doing it yes i'm excited i'm excited so i've been following you for years and i'm a huge fan of your work and i see more often than not these days
You sort of playing pickleball with all the GLP-1 misinformation and nonsense that comes constantly into our inboxes. I don't even get into it. I just let you do it.
You sort of playing pickleball with all the GLP-1 misinformation and nonsense that comes constantly into our inboxes. I don't even get into it. I just let you do it.
You sort of playing pickleball with all the GLP-1 misinformation and nonsense that comes constantly into our inboxes. I don't even get into it. I just let you do it.
Yes, yes. And then you have... really created this awesome, innovative direct care platform called Vineyard. So we're going to talk about that too, because I think what you're doing is exciting. I think you and I agree on a lot of things.
Yes, yes. And then you have... really created this awesome, innovative direct care platform called Vineyard. So we're going to talk about that too, because I think what you're doing is exciting. I think you and I agree on a lot of things.